ABSTRACT
Bioengineered foods, also known as genetically modified organisms (GMOs), are commodities or agricultural products that have been genetically modified by biotechnology. Genetic engineering implies the introduction or manipulation of specific genes into the DNA of an organism to confer desirable traits or characteristics. In current trends, the study of how individual genetic variations interact with diet and how this interaction affects health outcomes is a major issue. Bioengineered foods have generated significant public debate and controversy. Critics raise concerns about the potential long-term effects on human health, environmental impact, biodiversity, and the concentration of corporate control over the food supply. Advocates argue that GMOs have a long history of safe consumption and can contribute to addressing food security challenges and reducing agricultural inputs like pesticides. The collection and use of genetic data raise concerns about privacy, confidentiality, and the potential misuse of sensitive genetic information. Regulations need to address the protection of individuals’ genetic privacy and ensure appropriate consent and data security measures. Regulations should promote rigorous scientific standards for validating genetic markers, ensuring that the information provided to consumers is reliable and based on sound scientific evidence. These findings should address issues of affordability, accessibility, and potential disparities in accessing genetic testing. Coordinated efforts are required to ensure that existing regulatory frameworks appropriately address the unique challenges while avoiding duplication or conflicts with other regulations. Regulations should establish standards for practitioners offering services to ensure their functionality, competence, and adherence to ethical guidelines. Training and certification programs can help to ensure that practitioners have the necessary knowledge and skills to provide accurate and responsible advice based on genetic information. Different countries and regions have developed their own regulatory frameworks for bioengineered foods. These frameworks involve multiple regulatory agencies, including food safety authorities, agricultural departments, and environmental agencies. The regulations aim to ensure the safety, proper labeling, and appropriate assessment of bioengineered foods based on scientific evidence and risk analysis. International federal agencies, i.e., USDA-APHIS, EPA, FDA (USA), CFIA and Health (Canada), and European Food Safety Authority (EU), control GMOs under product-based rules. The Ministry of Environment, Forest, and Climate Change (MoEFCC) under EPA, 1986 regulates India. Codex also contains rules for assessing food safety from recombinant-DNA plants, animals, and microbes. However, each country may set its own policy for agriculture, pharmacy, and other areas. There are no worldwide labeling guidelines. Therefore, governments apply their own regulations. Critics argue that regulatory agencies may be influenced by industry interests, leading to biased decision-making. Building public trust and ensuring transparency in the regulatory process are essential to address these concerns. Addressing these issues requires careful consideration of scientific evidence, public input, and stakeholder engagement. Striking a balance between innovation, safety, and consumer rights is essential for effective regulation of bioengineered food.
